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Abstract
Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis, infects human neutrophils and
inhibits mitochondria-mediated apoptosis. Bacterial factors involved in this process are unknown. In the present study, we
screened a genomic DNA library of A. phagocytophilum for effectors of the type IV secretion system by a bacterial two-
hybrid system, using A. phagocytophilum VirD4 as bait. A hypothetical protein was identified as a putative effector, hereby
named Anaplasma translocated substrate 1 (Ats-1). Using triple immunofluorescence labeling and Western blot analysis of
infected cells, including human neutrophils, we determined that Ats-1 is abundantly expressed by A. phagocytophilum,
translocated across the inclusion membrane, localized in the host cell mitochondria, and cleaved. Ectopically expressed Ats-
1 targeted mitochondria in an N-terminal 17 residue-dependent manner, localized in matrix or at the inner membrane, and
was cleaved as native protein, which required residues 55–57. In vitro-translated Ats-1 was imported in a receptor-
dependent manner into isolated mitochondria. Ats-1 inhibited etoposide-induced cytochrome c release from mitochondria,
PARP cleavage, and apoptosis in mammalian cells, as well as Bax-induced yeast apoptosis. Ats-1(55–57) had significantly
reduced anti-apoptotic activity. Bax redistribution was inhibited in both etoposide-induced and Bax-induced apoptosis by
Ats-1. Taken together, Ats-1 is the first example of a bacterial protein that traverses five membranes and prevents apoptosis
at the mitochondria.
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Introduction
Infection of humans with rickettsia, Anaplasma phagocytophilum
leads to an acute febrile systemic disease called human
granulocytic anaplasmosis, which is classified as an emerging
infectious disease. Immune-compromised, elderly, or individuals
burdened with preexisting health conditions are at high risk for
severe complications that can result in death [1,2]. A. phagocyto-
philum is an obligatory intracellular bacterium that cannot
reproduce outside of eukaryotic cells due to the loss of many
genes present in free-living bacteria [3,4]. Paradoxically, this is
also one of few bacteria that are capable of specifically infecting
short-lived neutrophils, which are equipped with powerful anti-
microbial defense. It is noteworthy that A. phagocytophilum subverts
a number of host innate immune responses including programmed
cell death (apoptosis) [5].
Apoptosis of infected cells is one of the important innate
immune responses against intracellular pathogens, including
viruses, bacteria, and parasites [6]. Neutrophils typically undergo
spontaneous apoptosis within 6–12 h after release into the
peripheral blood from the bone marrow, an important process
in the maintenance of homeostatic levels of neutrophils and in the
resolution of inflammatory responses [7]. A. phagocytophilum
infection inhibits spontaneous and induced apoptosis of isolated
peripheral blood human neutrophils for up to 48 h and of
neutrophils in peripheral blood leukocyte cultures for up to 96 h as
determined by morphological observation [8]. This A. phagocyto-
philum anti-apoptotic phenomenon has been confirmed by several
in vitro studies on human neutrophils as well as by an ex vivo study
on ovine neutrophils infected in vivo with a sheep isolate
[9,10,11,12,13,14]. This delay of neutrophil apoptosis allows
sufficient time for the intracellular replication of the bacteria [8].
The cellular mechanisms by which A. phagocytophilum inhibits the
apoptosis of human neutrophils include inhibition of the loss of
mitochondrial membrane potential, Bax translocation to the
mitochondria, and the activation of downstream caspase 3
[12,13]. However, bacterial factors involved in these processes
are unknown.
Evolved from the bacterial conjugation system, the type IV
secretion (T4S) system transports macromolecules across the
bacterial membrane in an ATP-dependent manner into a diverse
range of eukaryotic cells [15]. The T4S system has been
recognized as the machinery for virulence factor delivery of host
cell-associated bacterial pathogens. The delivered bacterial
macromolecules referred to as T4S substrates or effectors can
dysregulate or modulate diverse eukaryotic target cell functions,
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three T4S substrates, BepA of Bartonella henselae, and SdhA and
SidF of Legionella pneumophila are known to be involved in host cell
apoptosis [16,17,18], although where these proteins are localized
in infected cells is unknown.
Encoding components of the T4S apparatus, Agrobacterium
tumefaciens virB/virD homologs have been identified in A.
phagocytophilum [4,19]. During the infection of human neutrophils
in vitro, virB9 and virB6, two T4S apparatus protein mRNAs and
VirB9 protein are up-regulated [20]. Although targeted manip-
ulation of genes currently is not applicable to obligatory
intracellular bacteria, VirD4-dependent secretion of the A.
phagocytophilum ankyrin repeat protein, AnkA, has been demon-
strated using the A. tumefaciens Cre recombinase reporter assay for
translocation [21].
A. tumefaciens VirD4, a component of the T4S apparatus
localized in the cytoplasmic membrane, is regarded as a coupling
protein, because it recognizes C-terminal sequences within T4S
substrate proteins prior to delivery into the VirB transmembrane
channel [22]. In the present study, we screened an A.
phagocytophilum genomic DNA library for T4S substrates by
bacterial two-hybrid system using A. phagocytophilum VirD4
(GenBank YP_505894) as bait. A hypothetical protein was
identified as a putative substrate, hereby named Anaplasma
translocated substrate 1 (Ats-1). Our results demonstrate that
Ats-1 is translocated across the bacterial and inclusion membranes,
localized in the mitochondrial matrix, or at inner membrane, and
cleaved in the infected cells. Given the distinct localization in the
mitochondria, the integrators of pro-and anti-apoptotic signaling,
we also address the possible role of Ats-1 in inhibition of
mitochondria-mediated host cell apoptosis. Our data suggest that
Ats-1 reduces the sensitivity of host cell mitochondria to apoptosis-
inducing stimulus by inhibiting Bax redistribution to the
mitochondria.
Results
Identification of VirD4-interacting proteins
To identify potential T4S effectors/substrates, we screened an
A. phagocytophilum genomic DNA library by bacterial two-hybrid
system using full-length A. phagocytophilum VirD4 as bait. One
hundred bacterial colonies were sequenced, the majority of which
(65%) encoded amino acid residues 9–253 of a 253-residue
hypothetical protein APH0859 (GenBank YP_505436). Eight
colonies encoded residues 210–332 of the 332-residue protein
VirB11 (GenBank YP_505895). The remaining 27 colonies
encoded various A. phagocytophilum proteins, each with a 1- or 2-
hit frequency. No colonies grew in selective media when empty
bait vector pBT and prey vector pTRG-APH0859 isolated from
bacterial two-hybrid screening were used to co-transform the E.
coli reporter strain, indicating that the interaction between VirD4
and APH0859 was specific (data not shown). This result indicates
that APH0859 is a potential substrate for the T4S system of A.
phagocytophilum. APH0859 is annotated in GenBank as a protein
with a predicted molecular mass of 27 kDa and a predicted pI of
6.64 [4]. The C-terminus of APH0859 (20 residues:
VTPLVSAQNRGPETHGKGTR) bears more basic amino acids
than the remainder of the protein, which is similar to A. tumefaciens
T4S substrates [23]. These 20 residues have a net positive charge
of +2.077 at pH 7.0, with a calculated pI of 10.89. The direct
interaction between the two inner membrane ATPases VirD4 and
VirB11 of A. phagocytophilum affirms the previously indicated
VirD4-VirB11 interaction in A. tumefaciens, which was shown by
genetic suppression, transfer DNA immunoprecipitation, and
coimmunoprecipitation experiments [24,25]. The interaction
between A. phagocytophilum VirD4 and A. phagocytophilum VirB11
suggests that A. phagocytophilum VirD4 may usher T4S substrates to
VirB11 prior to delivery to the core T4S channel, as demonstrated
in A. tumefaciens for delivery of T-DNA [26].
Secretion of A. phagocytophilum APH0859
If APH0859 is the true substrate of the T4S system, it is secreted
from the bacteria. In order to determine protein expression and
secretion, the gene aph0859, encoding the 253-residue protein, was
cloned into pET-33b(+) and expressed as a recombinant protein in
E. coli. The purified recombinant protein (Figure 1A) was used to
immunize rabbits. An antibody with monospecificity to recombi-
nant APH0859 (rAPH0859) was affinity-purified using rAPH0859-
conjugated Affi-gel 10 agarose. Using the anti-rAPH0859
antibody, Western blot analysis revealed one highly immunoreac-
tive protein of approximately 48 kDa, and one weakly immuno-
reactive protein of approximately 35 kDa in A. phagocytophilum-
infected HL-60 cells, a human promyelocytic leukemia cell line,
whereas no immunoreactive proteins were detected in uninfected
HL-60 cells (Figure 1B). Since the molecular mass of APH0859 in
the Western blot analysis was larger than the expected molecular
mass (27 kDa), the open reading frame (ORF) of aph0859 was
reanalyzed. Consequently, a new ORF for aph0859 (GenBank
FJ210653) was defined that encoded a protein of 376 residues
(calculated molecular mass: 40.3 kDa); the most upstream ATG
was designated as the translational start site. The new annotation
of this ORF was verified by several methods. First, when the 48-
kDa protein was immunoprecipitated from A. phagocytophilum-
infected HL-60 cell lysate using anti-rAPH0859 antibody, and
subjected to protein identification by mass spectrometry, a peptide
with the sequence matching only the N-terminus of the newly
defined APH0859 ORF was identified, in addition to several
peptides matching the previously annotated APH0859 (Figure 1C).
Second, recombinant expression of the new ORF in E. coli resulted
Author Summary
Anaplasma phagocytophilum is the pathogen that causes
human granulocytic anaplasmosis, an emerging infectious
disease. As an obligate intracellular organism, this bacte-
rium cannot reproduce outside of eukaryotic cells due to
the loss of many genes that are present in free-living
bacteria. Paradoxically, it specifically infects short-lived
white blood cells that play critical roles in anti-microbial
defense, by subverting a number of host innate immune
responses including programmed cell death (apoptosis). A.
phagocytophilum factors that are involved in this process
are largely unknown. In this study, we first searched A.
phagocytophilum proteins that are secreted by its special-
ized secretion system into eukaryotic cells. We found a
protein of unknown function, here named Ats-1, which is
abundantly produced by A. phagocytophilum and traverses
five membranes to enter the mitochondria of human cells.
Our further study showed that Ats-1 reduces the sensitivity
of mitochondria to respond to apoptosis-inducing factors,
leading to the inhibition of host cell apoptosis. Thus,
present findings identified a bacterial protein that allows
infected white blood cells to live longer to support
bacterial growth. The absence of similarity of the sequence
or the mode of action to any other known cell death
suppressor suggests that Ats-1 defines a previously
undescribed class of anti-apoptotic protein. This protein
and the mechanism thereof may provide insight regarding
a new therapeutic target for treatment of human
granulocytic anaplasmosis.
Ats-1 in Mitochondria-Mediated Apoptosis
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of the native APH0859 protein (data not shown). Third, when the
new ORF sequence was aligned with the Anaplasma marginale
ortholog AM410 (predicted molecular mass 43 kDa, GenBank
YP_153722), the N-terminal region of the newly defined APH0859
(residues 1–123) was similar to that of AM410 (E value=1.2e–09).
The 48-kDa protein encoded by this newly defined aph0859 ORF
was named Anaplasma translocation substrate 1 (Ats-1). Although
the basis for the discrepancy between the calculated molecular
mass of Ats-1 (40.3 kDa) and the mass (48 kDa) visualized by SDS-
PAGE remains elusive, such discrepancies have been observed for
other Anaplasma proteins such as AnkA [21].
To determine whether Ats-1 is expressed by A. phagocytophilum
and secreted into the host cell cytoplasm across the inclusion and
bacterial membranes, double immunofluorescence labeling was
performed. Since P44 is the major outer membrane protein of A.
phagocytophilum [27], monoclonal anti-P44 antibody 5C11 [28] was
used to label A. phagocytophilum, and rabbit anti-Ats-1 antibody was
used to localize Ats-1 following A. phagocytophilum infection of HL-
60 cells. Ats-1 was expressed and colocalized with A. phagocytophilum
at 22 h post-infection (p.i.) by double immunofluorescence
labeling. Ats-1 secretion into the host cell cytoplasm became
obvious after 32 h p.i. as the lack of P44 colocalization with a
portion of Ats-1 (Figure 2A). At 32 h and 42 h p.i, the percentage
of infected cells that secreted the Ats-1 signal was approximately
32 and 28%, respectively (Figure 2B). The 3-D shadow projection
image constructed based on the Z-stack data from confocal
microscopy, affirmed that Ats-1 was secreted into host cytoplasm
from A. phagocytophilum, and some of the protein remained
externally associated with the bacteria or bacterial inclusions
(Figure 2C). In addition, a 3-D reconstruction video is shown in
the supplementary data (Video S1).
Ats-1 targets host cell mitochondria in an N-terminal
sequence-dependent manner
The distribution of secreted Ats-1 in HL-60 cells was not
homogenous, but granular (Figures 2A and 2C). In addition, we
identified a mitochondrial localization signal at the N-terminus of
Ats-1 based on two in silico prediction programs: MitoProt (http://
ihg.gsf.de/ihg/mitoprot.html) and Predotar (http://urgi.versailles.
inra.fr/predotar/predotar.html) (Figure 1C) [29,30]. Therefore,
we examined whether secreted Ats-1 targets the mitochondria in
A. phagocytophilum-infected human neutrophils (natural host cells)
and HL-60 cells by triple immunofluorescence labeling. Horse
anti-A. phagocytophilum serum and Cy3-conjugated goat anti-horse
IgG were used to label A. phagocytophilum; rabbit anti-Ats-1
antibody and Alexa Fluor 488-conjugated goat anti-rabbit IgG
were used for Ats-1 labeling; mouse monoclonal anti-manganese
superoxide dismutase (Mn-Sod), a mitochondrial marker, and
Alexa Fluor 350-conjugated goat anti-mouse IgG were used for
mitochondria labeling as reported previously [13]. Some Ats-1
localized with A. phagocytophilum, and the rest of Ats-1 that did not
colocalize with A. phagocytophilum, colocalized with mitochondria in
infected human neutrophils and HL-60 cells (Figures 3A and 3B).
This result suggests that Ats-1 targets mitochondria after secretion
into the host cell cytoplasm. There was no cross-reaction or bleed-
through between the Ats-1 signal and Mn-Sod signal, as indicated
from the negative controls (Figures 3C and 3D).
To determine whether translocation to the mitochondria is an
intrinsic property of Ats-1, ats-1 was ectopically expressed in RF/
6A monkey endothelial cells. No tag was added to Ats-1 to prevent
mis-targeting, as it was found that GFP tag alters Ats-1 cellular
localization (Data not shown). A. phagocytophilum was shown
previously to infect endothelial cells in vitro and in vivo [31,32]. In
addition, RF/6A cells are more easily transfected than HL-60
cells, and the mitochondria can be more easily recognized under a
fluorescence microscope due to the characteristic filamentous and
flat shape of the cells (Figures 4B and 4C), whereas in neutrophils
and HL-60 cells, mitochondria and cells are round making them
difficult to focus simultaneously (Figures 3A, 3B, and 4A). Using
double immunofluorescence labeling, we determined that Ats-1
was expressed in pAts-1-transfected RF/6A cells and colocalized
with cytochrome c and Mn-Sod, indicating Ats-1 is translocated to
the mitochondria in the absence of any other bacterial factors
(Figures 4B and 4C). Ats-1 with the putative N-terminal
mitochondrial targeting sequence deletion (Ats-1DN17) showed
the diffuse distribution in RF/6A cells, indicating N17 of Ats-1 is
required for mitochondrial targeting (Figure 4D).
Ats-1 is cleaved in the mitochondria
Most of mitochondrial proteins are encoded by nuclear DNA in
eukaryotes, and many of them are translated as precursor proteins,
from which the N-terminal presequence including the mitochon-
Figure 1. Expression of APH0859 in Anaplasma phagocytophilum
and new annotation of aph0859 ORF. A. Truncated rAts-1 (derived
from predicted APH0859 ORF) expressed in E. coli was purified by
immobilized Ni
2+ affinity chromatography, and subjected to SDS-PAGE
analysis followed by Coomassie Brilliant blue staining. Lanes: M, protein
molecular mass marker; rAts-1, recombinant truncated A. phagocyto-
philum Ats-1. Arrow indicates rAts-1 migration. B. Western blot analysis
of A. phagocytophilum (Ap)-infected and uninfected HL-60 cells using
affinity-purified rabbit anti-Ats-1 antibody. Arrows 1 and 2 indicate full-
length native Ats-1 and cleaved Ats-1, respectively. Molecular mass
markers are indicated at the left. C. The amino acid sequence deduced
from the newly defined aph0859 (ats-1) ORF. The amino acid sequences
identified by mass spectrometry are highlighted in bold. The N-terminal
mitochondrial targeting sequence predicted by the Mitoprot program is
indicated in shaded bold. * indicates the stop codon.
doi:10.1371/journal.ppat.1000774.g001
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PLoS Pathogens | www.plospathogens.org 3 February 2010 | Volume 6 | Issue 2 | e1000774Figure 2. Translocation of Ats-1 from Anaplasma phagocytophilum into the cytoplasm of HL-60 cells. A. Double immunofluorescence
labeling of Ats-1 and P44 in A. phagocytophilum–infected HL-60 cells. Uninfected HL-60 cells and A. phagocytophilum-infected HL-60 cells at 22, 32, or
42 h post-infection were double immunofluorescence-labeled using mouse monoclonal anti-P44 (P44; Alexa Fluor 488, green) and affinity-purified
rabbit anti-Ats-1 (Ats-1; Alexa Fluor 555, red), and subjected to epifluorescence microscopy (22 or 32 h p.i.) or to confocal laser scanning microscopy
(42 h p.i.). Merged images with or without phase contrast micrograph are shown (Merge). N: nucleus. Yellow arrowheads indicate Ats-1 translocated
to the cytoplasm of host cells. Scale bar: 5 mm. B. Percentage of HL-60 cells with P44 signal having non-colocalized (secreted) Ats-1 signal at 22, 32 or
42 h p.i. One hundred A. phagocytophilum P44-positive HL-60 cells at 22, 32 or 42 h p.i. were scored, and the percentage of cells which has Ats-1
cytoplasmic signal was determined. Data are presented as the means and standard deviations of triplicate samples. C. A 3-D shadow projection
image was reconstructed based on the Z-stack data from confocal microscopy, performed for A. phagocytophilum-infected HL-60 cells at 42 h p.i.
Green color: P44; Red color: Ats-1.
doi:10.1371/journal.ppat.1000774.g002
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mitochondrial processing peptidase [33]. Although, there has
been no example of any native bacterial protein processed by the
mitochondrial matrix peptidase, we wondered whether native Ats-
1 is cleaved in the mitochondria, as two Ats-1 species (35 kDa and
48 kDa) were detected in A. phagocytophilum-infected HL-60 cells by
Western blot analysis (Figure 1B). The 48- and 35-kDa Ats-1s were
detected in the A. phagocytophilum and mitochondria pellet obtained
by 10,0006g centrifugation of the infected cell lysate (Figure 5A),
whereas only a single 48-kDa Ats-1 species was detected in A.
phagocytophilum isolated from the 10,0006g pellet by Percoll
density-gradient centrifugation (Figure 5A). Mitochondria (Mn-
Sod as marker) were mostly removed from Percoll density-gradient
purified A. phagocytophilum (Figure 5B). This result suggests that
native Ats-1 (48 kDa) was cleaved to 35 kDa after translocation to
the host cell mitochondria. In agreement with the results of
colocalization of almost all Ats-1 with mitochondria, when Ats-1
was ectopically expressed in RF/6A cells (Figures 4B and 4C), the
35-kDa species represented the major form (Figure 5C). This result
also confirms that Ats-1 was cleaved by the host cell protease. Ats-
1DN17 ectopically expressed in RF/6A cells, was not cleaved,
indicating Ats-1 mitochondrial localization is required for the
cleavage (Figure 5C).
Ats-1 is a precursor protein and the presequence is
cleaved at a specific site
To determine whether the N-terminal presequence is cleaved
from the precursor 48-kDa Ats-1 to generate the mature 35-kDa
Ats-1 in the mitochondria, a sequence encoding a hemagglutinin
Figure 3. Ats-1 localizes with mitochondria in host cells. A and B. Triple immunofluorescence labeling of A. phagocytophilum-infected human
neutrophils (A) and HL-60 cells (B) using horse anti-A. phagocytophilum (Anaplasma; Cy3, red), rabbit anti-Ats-1 (Ats-1; Alexa Fluor 488, green) and
monoclonal anti-Mn-Sod (Mn-Sod; Alexa Fluor 350, gray pseudocolor). Arrowheads indicate Ats-1 and mitochondria colocalization. Scale bar: 5 mm. C
and D. Negative controls for Ats-1 or Mn-Sod staining in A. phagocytophilum–infected HL-60. A. phagocytophilum–infected HL-60 cells were stained
with primary antibodies, horse anti-A. phagocytophilum, and rabbit anti-Ats-1 (C), or monoclonal anti-Mn-Sod (D), then stained with secondary
antibodies, Cy3-conjugated goat anti-horse IgG, Alexa Fluor 488-conjugated goat anti-rabbit IgG, and Alexa Fluor 350-conjugated goat anti-mouse
IgG (gray pseudocolor). Arrowhead indicates secreted Ats-1. Scale bar: 5 mm.
doi:10.1371/journal.ppat.1000774.g003
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expression plasmid at different locations to create plasmids
expressing Ats-1 (HA30), Ats-1 (HA45), Ats-1 (HA60), or Ats-1
(HA72) (Figure 6A). The mutant proteins were ectopically
expressed in RF/6A cells, and their mitochondrial localization
and cleavage were examined. All four Ats-1 mutants colocalized
with mitochondria [Figure 6B, only Ats-1 (HA45) is shown] and
cleaved, generating ,35-kDa species (Figure 6C). Thus, HA tag
insertion at these locations did not prevent Ats-1 mitochondrial
targeting. However, protease sensitivity of Ats-1 (HA30) and Ats-1
(HA45) was reduced compared to wild-type Ats-1, Ats-1 (HA60),
and Ats-1 (HA72), indicating that former insertions influence Ats-1
sub-mitochondrial processing. The ,35-kDa cleaved products of
Ats-1 (HA30) and Ats-1 (HA45) did not have the HA tag, but the
cleaved products of Ats-1 (HA60) and Ats-1 (HA72) did
(Figures 6C and 6D). The result indicates that the cleavage site
Figure 4. Mitochondrial targeting of Ats-1, and essential role of N-terminal sequence in targeting. A-C. Double immunofluorescence
labeling of A. phagocytophilum–infected HL-60 cells (A), or pAts-1-transfected RF/6A cells (B and C) using rabbit anti-Ats-1 (Ats-1; Alexa Fluor 488,
green), and monoclonal anti-Mn-Sod (Mn-Sod; Alexa Fluor 555, red) (A and C), monoclonal anti-cytochrome c (Cyto c; Alexa Fluor 555, red) (B). Scale
bar: 10 mm. D. Immunofluorescence labeling of RF/6A cells transfected with pAts-1DN17 was performed using anti–Ats-1 (Alexa Fluor 488, green). N,
nucleus. Note diffuse distribution of Ats-1DN17 in the cytoplasm of RF/6A cell. Scale bar: 10 mm.
doi:10.1371/journal.ppat.1000774.g004
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residues within Ats-1 residues 45–60 are important for cleavage,
the amino acids within this region were sequentially substituted
with AAA or AGA (Figure 6E). All five mutants colocalized with
mitochondria (Figure 6F, only Ats-1 (FYH55-57AAA) mutant
[Ats-1(55–57)] is shown). However, of the five mutants, substantial
cleavage inhibition was observed only for Ats-1(55–57) (Figure 6G).
These results indicate 48-kDa Ats-1 is a precursor to the 35-kDa
mature protein and that residues 55–57 of Ats-1 are critical for
processing to generate the mature Ats-1.
Ats-1 is routed to the mitochondrial matrix in receptor-
dependent manner
To further analyze mitochondrial targeting and the sub-
mitochondrial route of Ats-1, we performed in vitro import
experiments of
35S-labeled Ats-1 and its derivatives Ats-1 (55–
57) and Ats-1DN17. The
35S-labeled proteins were incubated
with isolated HeLa mitochondria and mitochondria then were
treated with protease K (PK) to remove any non-imported
protein. Ats-1 and Ats-1 (55–57) species were detected only in
the samples containing mitochondria, and not in the mock
samples, where no mitochondria were present, showing that Ats-
1 was not simply binding to or exposed to the outside of
mitochondria, but was imported into the interior of mitochon-
dria in the PK-inaccessible compartment (Figure 7A). Host cell
cytoplasmic modification of Ats-1 was not required for Ats-1
mitochondrial import, as in vitro transcribed and translated Ats-1
is imported into mitochondria. Additionally, a PK-resistant
protein was not detected when Ats-1DN17 was used for import,
indicating that the lack of Ats-1DN17 targeting to mitochondria
is an intrinsic property of this mutant, versus retention of this
protein in the cytoplasm of host cells. The amount of PK-
undigested Ats-1 increased with time; however, cleavage of the
35S-labeled protein was not detectable within 40 min of
incubation (Figure 7B).
In general, proteins targeted to mitochondria can take one of
several pathways to import into these organelles and sort into the
corresponding mitochondrial compartment. The translocase of the
outer mitochondrial membrane (TOM) complex is the entry point
of practically all mitochondria-targeted proteins. Subsequently,
proteins with a cleavable amino-terminal presequence are handed
over to the translocase of the inner mitochondrial membrane
(TIM) 23 complex and in most cases transported into the
mitochondrial matrix, whereas the carrier proteins, with internal
targeting signals, are integrated into the inner mitochondrial
membrane (IMM) via the TIM22 complex. The outer mitochon-
drial membrane (OMM) b-barrel proteins are assembled into the
OMM with the help of the sorting and assembly machinery
complex [34]. The isolated HeLa mitochondria were treated with
trypsin prior to import, in order to digest the parts of the TOM
import receptors exposed to the cytosol. Significantly less Ats-1
was imported into trypsin-pretreated mitochondria, pointing to the
likely involvement of the TOM import receptors in the import of
Ats-1 (Figure 7C).
In HeLa cells, both Ats-1 and Ats-1 (55–57) could be found in
mitochondria upon over-expression, whereas Ats-1 DN17 was
found only in the cytosol as in RF/6A cells (Figures 4B, 4C, 4D,
and 6F). In all cases, mitochondria retained their usual
morphology and membrane potential, as judged by the staining
of mitochondria with a membrane-potential sensitive dye
MitoTracker (Figure S1). In order to examine the sub-mitochon-
drial localization of Ats-1 and Ats-1 (55–57), mitochondria were
isolated after 24 h of expression in HeLa cells. Ats-1 was cleaved to
35-kDa in HeLa mitochondria as in RF/6A cells (Figure 5C),
however, Ats-1 (55–57) showed multiple bands ranging from
approximately 48 to 39 kDa, none of them corresponding to the
single 35-kDa band that was detected in Ats-1-containing
mitochondria (Figure 7D). Thus, in HeLa cells residues 55–57
are critical for proper cleavage of Ats-1 as in RF/6A cells
(Figure 6G) or in the case of native Ats-1 (Figure 1B). Next, the 35-
kDa Ats-1-containing mitochondria were incubated in an isotonic
and a hypotonic buffer, in the presence or in the absence of PK. In
addition, mitochondria were solubilized with 1% detergent Triton
X-100 and treated with PK. After opening of OMM by swelling of
mitochondria in the hypotonic buffer, the IMM protein Mitofilin,
which is exposed to the intermembrane space of mitochondria,
Figure 5. Ats-1 is cleaved in the mitochondria. A. Western blot analysis of the A. phagocytophilum- and mitochondria-containing pellet (Pellet)
after 10,0006g centrifugation, and A. phagocytophilum purified from the pellet by Percoll density-gradient centrifugation [AP (Percoll)] using anti-Ats-
1. Arrows 1 and 2 indicate full-length native Ats-1 and cleaved Ats-1, respectively. Molecular mass markers are indicated at left. B. Western blot
analysis of A. phagocytophilum (Ap)-infected HL-60 cells and percoll-purified A. phagocytophilum [AP (Percoll)], using mouse monoclonal anti-P44 and
rabbit anti-Mn-Sod. Molecular mass markers are indicated at left. C. Western blot analysis of pAts-1 or pAts-1DN17-transfected RF/6A cells using anti-
Ats-1. Ats-1 was cleaved in A. phagocytophilum (Ap)-infected HL-60 cells and pAts-1-transfected cells, but not in pAts-1DN17-transfected cells. Arrows
1 and 2 indicate full-length Ats-1 and cleaved Ats-1, respectively. Molecular mass markers are indicated at left.
doi:10.1371/journal.ppat.1000774.g005
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PLoS Pathogens | www.plospathogens.org 7 February 2010 | Volume 6 | Issue 2 | e1000774Figure 6. Ats-1 presequence is cleaved at a specific site. A. Schematic diagram indicating HA tag insertion and predicted cleavage sites in Ats-
1 mutants. The HA tag was inserted between residues 30 and 31, 45 and 46, 60 and 61, or 72 and 73 of Ats-1. MTS, predicted mitochondrial targeting
sequence, indicated by white bar. Black bar indicates cleaved Ats-1 fragments detected by Western blot analysis; Gray bar indicates the sequence
between MTS and cleavage site. Dashed lines indicate undetectable (degraded) N-terminal cleaved fragment. B. Immunofluorescence labeling of RF/
6A cells transfected with pAts-1 (HA45) using rabbit anti-Ats-1 [Ats-1(HA45); Alexa Fluor 488, green] and mouse monoclonal anti-Mn-Sod (Mn-Sod;
Alexa Fluor 555, red). Note mitochondrial localization of Ats-1 (yellow). Scale bar: 10 mm. C. Western blot analysis using anti-Ats-1 or monoclonal anti-
HA antibody was performed to examine Ats-1 cleavage in RF/6A cells transfected with recombinant plasmids encoding wild type Ats-1 or Ats-1
mutants with HA insertion at different locations. Molecular mass markers are indicated at left. D. Summarized result for Figure 6C. The molecular size
for four Ats-1 mutants in Western blot analysis using anti-Ats-1 (Ats-1) or anti-HA (HA) antibody for Ats-1 (49 kDa) and cleaved Ats-1 (35, or 36 kDa). +
indicates immunoreactivity; - indicates no immunoreactivity. Note the molecular mass of full-length Ats-1 or cleaved Ats-1 which has HA insertion
increases 1 kDa. E. Diagram showing sequential substitution of amino acid triplets within residues 46–60 of full-length Ats-1. The wild type Ats-1
sequence at residues 46–60 was shown at the top and the mutant sequences in this region are shown below. Substituted residues were indicated in
red. F. Immunofluorescence labeling of RF/6A cells transfected with pAts-1 (FYH55-57AAA) using rabbit anti-Ats-1 [Ats-1(FYH55-57AAA); Alexa Fluor
488, green] and mouse monoclonal anti–Mn-Sod (Mn-Sod; Alexa Fluor 555, red). Note mitochondrial localization of Ats-1 (yellow). Scale bar: 10 mm.
G. Western blot analysis using anti–Ats-1 was performed to examine Ats-1 cleavage in RF/6A cells transfected with recombinant plasmids encoding
wild type Ats-1 or the indicated Ats-1 triplet substitution mutant. Cleavage was inhibited only in cells expressing the Ats-1 (FYH55-57AAA) mutant.
Molecular mass markers are indicated at left.
doi:10.1371/journal.ppat.1000774.g006
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IMM from the matrix side, remained intact and could be digested
only when mitochondria were completely solubilized with Triton
X-100. Ats-1 behaved mostly as the matrix protein Tim44,
although a portion could be degraded with PK after the swelling of
mitochondria, pointing to possible partial IMM localization
(Figure 7D).
To further determine the state of Ats-1 sub-mitochondrial
localization, mitochondria containing over-expressed Ats-1 and
Ats-1 (55–57) were subjected to carbonate extraction with
100 mM Na2CO3, pH 11.5 to determine whether the protein is
membrane integrated or soluble. Integral membrane protein
Tom40 was found in the pellet after carbonate extraction, whereas
the soluble matrix protein Hsp60 was found in the supernatant.
Figure 7. Analysis of the import and sub-mitochondrial localization of Ats-1. A. Ats-1, Ats-1 (55–57) and Ats-1 DN17
35S-labeled proteins
were imported into isolated HeLa mitochondria for 45 min and treated with 50 mg/ml of protease K (PK). Mock samples contain no mitochondria. B.
35S-labeled Ats-1 was imported into isolated HeLa mitochondria for given time periods, and samples were left untreated (-PK) or treated with 50 mg/
ml of protease K (+PK). Two ml of lysate of Ats-1 and Ats-1 DN17 was resuspended in Laemmli buffer and analyzed on the gel in addition. C.
Mitochondria were left untreated (-Trypsin) or treated with 0.02 mg/ml of trypsin (+Trypsin) prior to the import. Import was then performed as in (A)
and (B). Signals were quantified using ImageQuant. The import at the longest time point in -Trypsin mitochondria was set as 100%. D. HeLa cells were
transfected with plasmids containing Ats-1 or Ats-1 (55–57). Mitochondria were isolated after 24 h of overexpression. Mitochondria were incubated in
isotonic buffer (- SW), or were swollen in hypotonic buffer (+SW), and then were left untreated (-PK) or treated with 50 mg/ml of protease K (PK). In
one sample, mitochondria were solubilized by 1% Triton X-100 (1% Triton), treated with PK and proteins were precipitated using trichloroacetic acid.
In addition, 50 mg of mitochondria isolated from cells expressing Ats-1 (55–57) [HeLa Ats-1(55–57)] was resuspended in Laemmli buffer and all
samples were analyzed by SDS-PAGE and Western blot, using antibodies against Mitofilin, Tim44 or Ats-1. E. Ats-1 in mitochondria behaves as a
soluble protein. Ats-1 or a mutant, processing deficient form of the protein Ats-1 (55–57) were expressed in HeLa cells for 24 h. Mitochondria were
isolated and subjected to carbonate extraction with 100 mM Na2CO3, pH 11.5. After centrifugation for 1 h at 100,000 g, pellet (P) and supernatant (S)
fraction were separated and, together with total mitochondria, analyzed by SDS-PAGE and Western blot. Membrane was probed with Ats-1, Tom40
and Hsp60 antibodies.
doi:10.1371/journal.ppat.1000774.g007
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being soluble. For over-expressed Ats-1 (55–57), we could observe
two prominent bands, one corresponding to the misprocessed 39-
kDa protein and the other at approximately 48 kDa (Figure 7E).
The misprocessed protein behaved as a soluble protein, similar to
the properly processed Ats-1, whereas the 48-kDa protein was
found in the pellet fraction, suggesting that uncleaved Ats-1 (55–
57) is stacked in the mitochondrial membrane. We conclude that
mature Ats-1 most likely is present as a soluble protein in the
matrix of mitochondria, whereas most Ats-1 (55–57) is missorted
and misprocessed in the mitochondria.
Mature Ats-1 inhibits apoptosis in mammalian cells at the
mitochondria
A. phagocytophilum infection inhibited mitochondria-mediated
apoptosis in human neutrophils [12]. Given that Ats-1 was routed
to the mitochondrial matrix in A. phagocytophilum-infected cells, we
wondered whether mature Ats-1 is involved in apoptosis
inhibition. Etoposide, a topoisomerase II inhibitor, causes DNA
damage leading to the activation of caspase 2 and subsequent
induction of Bax translocation to mitochondria and cytochrome c
release [35]. Therefore, we treated pGFP-, pAts-1-, or pAts-1 (55–
57)-transfected RF/6A cells with etoposide. Ats-1 and Ats-1 (55–
57) localized in mitochondria as shown in Figures 4 and 6, but
GFP showed diffuse distribution. Most of the Ats-1-expressing
RF/6A cells were spread-out flat with a homogeneously oval shape
of nucleus, and elongated mitochondria retaining both Ats-1 and
cytochome c at day 1 after treatment with etoposide (Figures 8A
and D). However, ,50% of GFP-expressing RF/6A cells and
,40% of Ats-1 (55–57)-expressing RF/6A cells were apoptotic as
judged by rounded shrunken cell morphology, condensed and
fragmented nuclei, and release of cytochrome c into the cytosol
(diffuse staining, instead of distinct mitochondrial staining)
(Figures 8B, 8C, and 8D). In pAts-1 (55–57)-transfected cells,
both Ats-1 (55–57) and cytochrome c appeared to be retained in
some fragmented mitochondria (Figure 8B).
The pro-apoptotic Bcl-2 family protein Bax is found mainly in
the cytoplasm or loosely attached to OMM as inactive monomers
in non-apoptotic cells [36]. Following any one of various cytotoxic
signals, Bax is activated and undergoes a series of conformational
changes in the N- and C-termini, leading to Bax translocation to
the mitochondria, oligomerization, and integration into the
mitochondrial membranes [37,38]. These events have all been
implicated in the process of cytochrome c release, although the
precise biochemical sequence of events for Bax redistribution to
mitochondria and cytochrome c release is still unclear [39]. One
day after treatment with etoposide, Bax redistribution to
mitochondria containing Ats-1 (55–57) and Bax clumping in
GFP-expressing apoptotic RF/6A cells were observed (Figures 8E
and 8F). As it was difficult to recognize clumped Bax in many
apoptotic cells, we scored only the cells that we could recognize
with confidence. Bax was so diffuse in the thinly spread cytoplasm
of Ats-1-transfected cells that it was barely visible even after
etoposide treatment (Figure 8E). It is important to note that the
total cellular Bax amount was not obviously different between Ats-
1- and GFP-transfected RF/6A cells after etoposide treatment
(Figure 8G). From these studies, we concluded that mature Ats-1
inhibits Bax redistribution.
The release of cytochrome c from mitochondria is an important
step in mitochondria-mediated apoptosis, leading to activation of
caspase 9 and then caspase 3 [40]. Poly (ADP-ribose) polymerase
(PARP) is involved in DNA repair in response to environmental
stress [41]. During apoptosis, full length PARP (116 kDa) is
cleaved into an 89-kDa fragment by caspase 3 [42,43]. The
relative ratio of cleaved PARP to actin was lower in Ats-1-
transfected RF/6A cells than in GFP-, or Ats-1 (55–57)-transfected
RF/6A cells 12 h after etoposide treatment (Figure 8H). However,
the expression levels of Ats-1 and Ats-1 (55–57) in RF/6A cells
were similar (Figure 8H). This result is in agreement with
immunofluorescence labeling of cytochrome c, DAPI, and Bax
(Figures 8A-F), indicating that mature Ats-1 in the mitochondria
inhibits etoposide-induced apoptosis. Without etoposide treat-
ment, there is only minor cleavage of PARP after transfection with
these plasmids (Figure 8H).
Ats-1 inhibits Bax-induced apoptosis in yeast cells
Although yeast lacks Bcl-2 members, Apaf-1, and p53, the cell
death-regulating activity of Bcl-2 members is conserved in yeast
and it is well known that heterologous expression of human Bax
induces growth arrest and cell death in yeast cells [44]. Human
Bax translocates to yeast mitochondria and induces apoptotic
changes, which can be prevented by human Bcl-XL co-expression
[44,45]. To further analyze the anti-apoptotic mechanism of Ats-1
at mitochondria, we tested whether Ats-1 and Ats-1 (55–57) could
target mitochondria in Saccharomyces cerevisiae, and reduce sensitivity
to the apoptosis induced by human Bax. Both Ats-1 and Ats-1 (55–
57) localized to the yeast mitochondria (Figure 9A), indicating the
robust Ats-1 mitochondria localization signal. Also in yeast, over-
expressed Ats-1 was more effectively cleaved to the 35 kDa size as
observed in mammalian mitochondria, suggesting it was imported
to the matrix. In contrast, Ats-1 (55–57) cleavage was less
pronounced and aberrant, suggesting a limited accessibility to or
recognition by the matrix protease (Figure 9B). Ats-1, and, to a
significantly lesser extent, Ats-1 (55–57), could partially rescue S.
cerevisiae from Bax-induced apoptosis (growth arrest and death)
(Figure 9C). While the total Bax expression level did not change,
Bax translocation to yeast mitochondria was reproducibly reduced
by Ats-1 as compared to Ats-1 (55–57) or control plasmid
(Figure 9D). S. cerevisiae porin was used as loading control for the
amount of mitochondria in Western blot analysis. The transferred
membrane was also stained with ponceau S to compare total
protein loading amount and profile among samples (Figure S2).
Taken together, these results suggest mature Ats-1 in the matrix
renders mitochondria resistant to Bax docking, resulting in yeast
rescue.
Discussion
Our result showed that native Ats-1 is secreted and localizes to
the mitochondria in infected human neutrophils and HL-60. It is
important to note that Ats-1 is abundant, similar to AnkA [21],
allowing us to detect the native protein in the natural host (human
neutrophils). The abundance of Ats-1 and AnkA suggests that
these A. phagocytophilum T4S substrates are not toxic to the host
cells, but rather harness or promote intracellular survival and
growth of bacteria at the expense of substantial bacterial energy.
This is distinct from many substrates of T4S of Legionella, Coxiella,
Bartonella,o rBrucella in which secretion was detected by using
transformed bacteria [46,47,48,49]. Notably, when fused with
GFP tag, Ats-1 did not localize to the mitochondria, underscoring
the importance of verifying the ectopic expression results with the
native protein in the natural host. Timing of mitochondrial
translocation of Ats-1 was mid-log phase of the A. phagocytophilum
intracellular growth, approximately coinciding with the up-
regulation of VirB9 and VirB6, components of the T4S apparatus
of A. phagocytophilum [20]. Similar to A. phagocytophilum T4S
substrate AnkA [21], the C-terminus of Ats-1 contains basic
amino acids. Further studies are needed to characterize the
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PLoS Pathogens | www.plospathogens.org 10 February 2010 | Volume 6 | Issue 2 | e1000774Figure 8. Ats-1 inhibits etoposide-induced apoptosis. A-C. Triple fluorescence labeling using rabbit anti-Ats-1 [Ats-1 or Ats-1(55–57); Alexa
Fluor 488, green], mouse monoclonal anti-cytochrome c (Cyto c; Alexa Fluor 555, red), and DAPI (nucleus, gray pseudocolor) in RF/6A cells transfected
with pAts-1 (Ats-1) (A), pAts-1 (55–57) [Ats-1(55–57)] (B), or pGFP (GFP) (C), after treatment with etoposide. Scale bar: 10 mm. Note mitochondrial
colocalization of Ats-1, a large nucleus, and a spread-out large RF/6A cell in A, and round-up shrunken RF/6A cells with condensed nuclei and
presence of diffuse cytochrome c released into the cytosol in B and C. Some Ats-1 (55–57) is colocalized with cytochrome c retained in the
fragmented mitochondria in B (white arrowhead). Contours of host cells are marked with white dashed lines. D. Percentage of apoptotic cells in RF/
6A cells transfected with pAts-1 (Ats-1), pAts-1 (55–57) [Ats-1(55–57)], or pGFP (GFP) 1 day after etoposide treatment. Data are presented as means 6
standard deviations of triplicate samples. *, significantly different compared with GFP-, or Ats-1(55–57)-expressing RF/6A cells by the Tukey’s HSD test
(P,0.01). E. Bax staining for RF/6A cells transfected with pAts-1 (Ats-1), pAts-1(55–57) [Ats-1(55–57)], or pGFP (GFP) 1 day after etoposide treatment.
Note clumped Bax in the round-up shrunken pAts-1(55–57)- and pGFP-transfected cells, and weak diffuse Bax (almost invisible) in pAts-1-transfected
cells, and absence of Bax colocalization with Ats-1 in the mitochondria. In pAts-1(55–57)-transfected cells some Bax is colocalized with Ats-1(55–57)
retained in the fragmented mitochondria (white arrowhead). Bar: 10 mm. Contours of host cells are marked with white dashed lines. F. Percentage of
RF/6A cells transfected with pAts-1(Ats-1), pAts-1(55–57) [Ats-1(55–57)], or pGFP (GFP), showing obvious Bax redistribution (clumping) 1 day after
etoposide treatment. Data are presented as means 6 standard deviations of triplicate samples. *, significantly different compared with GFP-, or Ats-
1(55–57)-expressing RF/6A cells by the Tukey HSD test (P,0.01). G. Bax amount in RF/6A cells transfected with pAts-1(Ats-1), or pGFP (GFP) 1 day
after etoposide treatment. Actin is used to normalize the protein loading amount. H. Western blot analysis for cleavage of PARP in RF/6A cell
transfected with pAts-1 (Ats-1), pAts-1(55–57) [Ats-1(55–57)], or pGFP (GFP) after treatment with etoposide or DMSO for 12 h. Samples were
subjected to probing with anti-PARP, anti-actin, or anti-Ats-1 by Western blot analysis. Full-length and cleaved PARP, actin, full-length and cleaved
Ats-1 are indicated with arrows. Relative density ratios of cleaved PARP/actin bands, or total Ats-1 (full length, cleaved and degraded Ats-1)/actin
bands are shown below each lane in etoposide-treated group.
doi:10.1371/journal.ppat.1000774.g008
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Unlike AnkA, no phosphorylation or other host signaling motifs
have been detected in Ats-1 thus far, except the mitochondrial
localization signal.
Ats-1 is the first example of a bacterial protein that traverses five
membranes to localize in the mitochondrial matrix. Ectopically
expressed Ats-1 targets mitochondria in various mammalian cells
and yeast like native A. phagocytophilum Ats-1. Furthermore, in vitro
translated Ats-1 was translocated to isolated mitochondria in a
cell-free system, indicating that Ats-1 alone is sufficient for sub-
mitochondrial targeting. Most mitochondrial proteins are encoded
in the nucleus and synthesized by ribosomes in the cytoplasm as
precursor proteins containing cleavable N-terminal presequence
essential for mitochondrial targeting [33]. Our results showed that
Figure 9. Ats-1 inhibits Bax-induced apoptosis in yeast. A. Mitochondrial colocalization of Ats-1 and Ats-1(55–57) in S. cerevisiae. pYAts-1 (Ats-
1), pYAts-1(55–57) [Ats-1(55–57)], or pGADT7 AD(GADT7)–transformed YPH499 yeast cells were loaded with MitoTracker Red, and subjected to
immunostaining using rabbit anti-Ats-1, and Alexa Fluor 488-conjugated goat anti-rabbit IgG. Scale bar: 5 mm. B. Expression of Ats-1, or Ats-1(55–57)
in S. cerevisiae. The cell lysates of YPH499 cells transformed with pYAts-1 (Ats-1), pYAts-1(55–57) [Ats-1(55–57)], or pGADT7 AD(GADT7) were
subjected to Western blot analysis using anti-Ats-1. Note 35-kDa mature Ats-1 from wild type Ats-1 and abnormal cleavage of Ats-1(55–57). C. Ats-1
partially rescues S. cerevisiae from Bax-induced growth arrest. Yeast YPH499 cells were co-transformed with pBax, and pGADT7 AD (GADT7), pYAts-
1(55–57) [Ats-1(55–57)], or pYAts-1(Ats-1). Recombinant yeast cells were cultured in SG medium containing galactose to induce Bax expression. The
number of viable yeast cells was determined by plate count technique. The numbers of viable cells at day 5 after Bax induction were compared to the
viable cells at day 0. Data are presented as means and standard deviations of three independent experiments. * and **, Significantly different among
each other by Tukey’s HSD test (P,0.05). D. Translocation of Bax to mitochondria in S. cerevisiae. After induction to express Bax for 12 h, the total cell
lysates and mitochondria isolated from YPH499 cells co-transformed with pBax, and pGADT7 AD (GADT7), pYAts-1(55–57) [Ats-1(55–57)], or pYAts-
1(Ats-1), were subjected to Western blot analysis using anti-Bax, and anti- S. cerevisiae Porin. Relative density ratios of Bax/Porin bands are shown
below each lane.
doi:10.1371/journal.ppat.1000774.g009
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are critical for mitochondrial targeting. Deletion of this sequence
not only prevented mitochondrial targeting, but subsequently
prevented presequence cleavage. The presequence is cleaved from
preproteins by the matrix-located mitochondrial processing
peptidase after import into the mitochondrial matrix. Prese-
quences vary in length and share little sequence similarity.
However, a high content of positively charged residues and a
capacity to form an amphipathic a-helix are common character-
istics [33]. In addition, cleavage sites commonly contain a basic
amino acid residue, usually arginine, at the -2 position [50]. Our
result showed that the cleavage site of Ats-1 is between residues
45–60, and further, that residues 55–57 are crucial in facilitating
proper cleavage. Since only one arginine at position 58 is present
in this segment between residues 45–60 of Ats-1, it suggests that
cleavage may occur between residues 59 and 60.
Ats-1 is likely to follow the classical mitochondrial import route,
involving the TOM complex in the OMM. Indeed, we could show
that Ats-1 import likely depends on the TOM import receptors.
Interestingly, although mostly processed Ats-1 was detected in
mitochondria after the over-expression of the protein for 24 h in
HeLa, RF/6A, and yeast cells, we could not see any processing of
the presequence of Ats-1 after in vitro import. One possible reason
for this is that the processing of Ats-1 takes longer than the 40 min
time-period that we could observe in in vitro import experiments. In
this aspect, Ats-1 is different from endogenous mitochondrial
presequence-containing proteins, where the processing of the
presequence takes place within minutes upon import [51]. Related
to mitochondrial transport, it was reported that the depletion of
either Tom40 or Tom22 reduces Chlamydia caviae infection in
HeLa cells by unknown mechanisms [52]. Effectors targeting host
cell mitochondria have been described previously for pathogenic
bacteria utilizing a type III secretion system [53,54,55]. However,
the mitochondrial localization routes are not known. In addition,
their biological functions are opposite to Ats-1: enteropathogenic
Echerichia coli EspF is required to initiate apoptosis [53]. Moreover,
several effectors of Pseudomonas syringae are deleterious when
expressed in yeasts [54]. The biological function of SopA from
Salmonella enterica colocalized with mitochondria is unknown [55].
Recently, two T4S substrates were shown to target mitochon-
dria: when ectopically expressed in HeLa cells, Coxiella burnetii
AnkJ-mCherry colocalized to the mitochondria [47], although
where and how AnkJ is localized in the mitochondria and whether
AnkJ localizes in mitochondria of infected cells is unknown.
Ectopically expressed His- LegS2 and Myc-tagged LegS2 secreted
by L. pneumophila surround the mitochondria from the outside and
form patches on the mitochondrial outer membrane [56]. How
LegS2 is localized to mitochondria is unknown. Furthermore,
what the exact contributions of AnkJ and LegS2 to the
pathogenesis are not known. Our results with mitochondrial
fractionation and carbonate extraction point to Ats-1 being a
soluble or loosely membrane-associated matrix protein. This is not
surprising, considering that the protein possesses a cleavable
amino-terminal presequence, which is a hallmark of most
mitochondrial matrix proteins. To our knowledge, Ats-1 is the
first bacterial T4S substrate with a robust targeting presequence to
access the mitochondrial matrix, which may serve as a tool to
dissect exogenous protein import in the mitochondria.
Although not localized to mitochondria, several bacterial
proteins can inhibit apoptosis of eukaryotic cells, at upstream of
mitochondria by various mechanisms [57]. The C. trachomatis
protease, CPAF secreted into the host cell cytosol by an unknown
mechanism, can degrade the pro-apoptotic BH3-only proteins
[58]. However, it remains to be determined whether CPAF alone
in the absence of chlamydial infection can degrade the BH3-only
proteins inside cells and prevent host cells from undergoing
apoptosis. C. trachomatis recruits BAD to its vacuole by unknown
mechanism, which correlates with host-cell survival [59], and
infection-induced upregulation of IAPs and Mcl-1 is required to
keep the cells in an apoptosis resistant state [60,61]. Ectopically
expressed BepA of B. henselae localizes to the plasma membrane
and inhibits vascular endothelial cell apoptosis with a concomitant
increase in cellular cyclic AMP [17]. Macrophages infected with
an L. pneumophila sdhA mutant undergo apoptosis [16]. Which
subcellular compartment SdhA is localized, and how this protein
acts to block cell death activity remain to be determined. Mouse
macrophages infected with an L. pneumophila SidF mutant also
undergo apoptosis, and HeLa cells ectopically expressing L.
pneumophila SidF are resistant to apoptosis induced by staurospor-
ine. Ectopically expressed SidF localizes to the ER, and SidF
interacts with pro-death members of the Bcl2 protein family,
BNIP3 and Bcl-rambo as shown by various methods including
U937 cells infected with a SidF overproducing strain, although this
interaction was not detected with the wild-type strain [18]. PorB,
outer membrane protein of Neisseria meningitides is the only bacterial
protein known to target mitochondria and inhibit apoptosis [62].
Upon incubation of mammalian cells with isolated PorB, it targets
and binds mitochondrial outer membrane VDAC (voltage-
dependent anion channel), and inhibits host cell apoptosis [62].
Ectopically expressed Ats-1 directly translocates to the mitochon-
drial matrix and inhibits Bax translocation and cytochrome c
release from the mitochondria following treatment with etoposide.
Bax-induced, mitochondria-mediated yeast apoptosis was also
abrogated when Ats-1 was localized in mitochondria. These are
not isolated events with ectopic expression, but rather coincide
with cellular events observed in human neutrophils infected with
A. phagocytophilum [12,13]. In view of the likely matrix/inner
membrane localization of Ats-1, it is possible that Ats-1 stabilizes
the mitochondrial membrane potential or even the inner-
membrane cristae structure (the rearrangement of which was
shown to be required for apoptosis [63]). Since soluble mature Ats-
1 is more effective in apoptosis inhibition than insoluble and mis-
cleaved Ats-1 (55–57), Ats-1 sub-mitochondrial routing and/or
processing seem to be critical for proper function. Unlike vMIA of
cytomegalovirus, which is a mitochondrial OM-localized inhibitor
of apoptosis that causes mitochondrial fragmentation [64], over-
expressed Ats-1 did not have obvious adverse effects on
mitochondria in RF/6A, HeLa, HL-60, or yeast cells. It is
possible that Ats-1 has additional roles in facilitating A.
phagocytophilum infection.
Mature Ats-1 in mitochondria inhibited Bax redistribution to
these organelles. Since Bax is a cytosolic protein and Bax
translocation to mitochondria is often considered to be regulated
by the Bcl-2 family proteins and, therefore, is separated spatially
from the mitochondrial matrix protein, Ats-1, we want to
specifically address this issue. First, in the absence of Bcl-2 family
proteins in yeast, Ats-1 inhibited Bax docking to the mitochondria
and apoptosis, indicating that other Bcl-2 family members are not
important in this process. Second, alterations in mitochondrial
physiological conditions regulate Bax docking to mitochondria.
For example, neither an uncoupler of oxidative phosphorylation,
FCCP nor the F(1)-F(0) ATPase inhibitor, oligomycin alone alters
Bax location in mammalian cells. However, the combination of
the mitochondrial uncoupler FCCP and oligomycin, or com-
pounds that collapse mitochondrial membrane potential such as
antimycin and rotenone, trigger Bax docking to mitochondria
[65]. Translocation/activation of Bax occurs not only upstream of
cytochrome c release, but also downstream of cytochrome c release
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are also influenced by the lipids in the mitochondrial outer
membrane [67]. Studies primarily showed Bax association with
mitochondrial fission sites with the inner membrane protein
mitofilin and dynamin-related protein 1 [65]. Bcl2 and Bax have
been found at the mitochondrial contact sites [68,69] where the
outer and inner mitochondrial membranes are in close contact
and are virtually indistinguishable. Thus, it is possible that mature
Ats-1 in the matrix may loosely associate with inner membrane
and stabilize membrane potential, influence mitochondrial
energizing, or mitochondrial membrane conformation, making
them more resistant to Bax docking. Since Ats-1 is the first
bacterial T4S protein targeted to the mitochondrial matrix,
detailed mechanisms of apoptosis inhibition by Ats-1 at mito-
chondria deserve further study.
In conclusion, our data present the first example of a bacterial
protein that traverses five membranes via a characterized route
and processing to inhibit apoptosis at mitochondria. In the future,
vaccines or drugs designed to target the anti-apoptotic mechanism
of A. phagocytophilum Ats-1 may prevent this organism from
proliferating in its host cells, leading to the control of human
granulocytic anaplasmosis. The absence of sequence similarity or
mode of action to any other known cell death suppressors suggests
that Ats-1 defines a previously undescribed class of anti-apoptotic
protein.
Materials and Methods
GenBank accession number
VirD4: YP_505894; APH0859: YP_505436; VirB11: YP_505895;
AM410: YP_153722; ats-1: FJ210653.
Anaplasma phagocytophilum, isolation and cell culture
A. phagocytophilum HZ strain was propagated in HL-60 cells
(American Type Culture Collection (ATCC), Manassas, VA) in
complete RPMI 1640 medium (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal bovine serum (US Biotechnologies,
Parkerford, PA) and 2 mM L-glutamine (Invitrogen). RF/6A
monkey endothelial cells (ATCC) were cultured in advanced
MEM (Invitrogen), supplemented with 10% fetal bovine serum
and 2 mM L-glutamine. Cultures were incubated at 37uC under
5% CO2 in a humidified atmosphere. Human neutrophils were
isolated by Dextran sedimentation followed by Hypaque gradient
centrifugation, and subjected to infection with A. phagocytophilum,a s
described previously [20]. Host cell-free A. phagocytophilum was
prepared by sonication or nitrogen cavitation, as described
elsewhere [20]. For cellular fractionation, 1.5610
8 A. phagocytophi-
lum–infected HL-60 cells were resuspended in 25 ml RPMI 1640
medium and subjected to nitrogen cavitation. The cellular fraction
containing A. phagocytophilum and mitochondria was pelleted by
centrifugation at 10,0006g for 10 min at 4uC. A. phagocytophilum
was further purified from the pellet by Percoll density-gradient
centrifugation, as described elsewhere [70]. HeLa cells were grown
in RPMI 1640 (Gibco) supplemented with 10% fetal calf serum
(Biochrom) and penicillin/streptomycin.
Bacterial two-hybrid system
Genomic DNA was isolated from Percoll density gradient–purified
A. phagocytophilum. The DNA fragment encoding residues 2-740
of VirD4 was amplified by PCR using the forward primer
59-AGTGCGGCCGCACATAGTTCCAATCATATACGAAA-39,
(Not I site is underlined) and the reverse primer 59-TTACTC-
GAGCTACTTTAGTCTTCCGTTACT-39 (Xho I site is under-
lined) from genomic DNA. The PCR product was digested with Not
I and Xho I and ligated into the pBT plasmid (BacterioMatch II
two-hybrid system; Stratagene, La Jolla, CA). Ligated products were
transformed into XL1-Blue (MRF’ Kan strain; Stratagene), resulting
in recombinant bait plasmid, pBT-VirD4.
To construct the random genomic DNA library of A.
phagocytophilum, the pTRG prey plasmid from the BacterioMatch
II two-hybrid system was first modified by introducing two BstXI
sites into the multiple cloning sites. To insert the first BstXI site,
PCR amplification was performed using pTRG as a template
and the following pair of primers: pTRG BstXI Forward I, 59-C-
GAGGATCCAGTGTGGTGGCGGCCGCAAGAATTCAGTCT-
39 (BamH I and Not I sites are underlined, BstXI site is italicized)
and pTRG BstXI Reverse I, 59-CGCGGATCCGGCCGCC-
TCTGGTTTCTCTT-39 (BamH I site is underlined). The PCR
product was digested with BamH I and self-ligated, resulting in the
insertion of the first BstXI site between the BamH I and Not I sites
in pTRG vector. For the insertion of the second BstXI site, PCR
amplification was performed using the partially modified pTRG as
template and the second pair of primers: pTRG BstXI Forward
II: 59-CGACTCGAGCCAGCACAGTGTAATTAATTAATTAAT-
GAACTAGTGAGATC-39 (Xho I site is underlined and BstXI
site is italicized) and pTRG BstXI Reverse II 59-CGC-
CTCGAGCGCCAGCTCAGACTGAATTC-39 (Xho I site is
underlined). The PCR product was digested with Xho I and
self-ligated, resulting in the insertion of the second BstXI site
downstream of the Xho I site.
A. phagocytophilum genomic DNA (10 mg) was fragmented by
nebulization (Invitrogen) according to the manufacturer’s instruc-
tion. Fragmented DNA (0.5 to 3.0 kb) was ligated with a BstXI
adapter (Invitrogen) after its termini were repaired and phosphor-
ylated. BstXI-adapted genomic DNA fragments were ligated into
BstXI-digested modified pTRG vector and transformed into XL1-
Blue MRF’ Kan cells by electroporation, according to the
manufacturer’s instruction (MicroPulser Electroporator, Bio-Rad,
Hercules, CA). After incubation at 30uC for 24 h, transformants
were harvested and recombinant plasmids were purified using a
QIAprep Maxi kit (Qiagen).
Screening of the random genomic DNA library for
VirD4-interacting protein
A mixture of 50 ng pBT-VirD4 vector and 50 ng pTRG library
DNA was transformed into BacterioMatch II electrocompetent
reporter cells (Stratagene) via electroporation. Transformants were
screened according to the manufacturer’s instruction. Positive
interactions were identified by growth on selective screening
medium consisting of minimal medium plus 5 mM 3-amino-1,2,4-
triazole (3-AT), 25 ng/ml chloramphenicol and 12.5 ng/ml
tetracycline for 40 h (24 h at 37uC, and then 16 h at room
temperature) and validated by growth on dual selective screening
medium consisting of minimal medium plus 5 mM 3-AT,
12.5 ng/ml streptomycin, 25 ng/ml chloramphenicol and
12.5 ng/ml tetracycline. All media were prepared according to
the manufacturer’s instruction (BacterioMatch II two-hybrid
system; Stratagene). False positive controls for bait and prey were
performed using pBT-VirD4 and empty prey vector, or empty bait
vector and pTRG-prey.
Expression of recombinant APH0859, antibody
production, and affinity purification
A 765-bp DNA fragment encoding APH0859 was amplified by
PCR using A. phagocytophilum genomic DNA as template, and
cloned into pET33b (+) protein expression vector (Novagen,
Madison, WI). Primer set (APH0859 Expression Forward, and
Ats-1 in Mitochondria-Mediated Apoptosis
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Supplementary data (Table S1). The recombinant plasmid was
transformed into E. coli BL21(DE3) (Novagen) and cultures were
grown in Luria–Bertani (LB) medium. The expression of
recombinant APH0859 (rAPH0859) was induced at 25uC for
5 h by addition of isopropyl-beta-D-thiogalactopyranoside (1 mM
final). rAPH0859 was affinity-purified using a HisBind Quick
Column under non-denaturing conditions as instructed by the
manufacturer (Novagen). The purified protein was subjected to
SDS-PAGE analysis and the rAPH0859 band was excised and
used to prepare antiserum in rabbits (Prosci Incorporated, Poway,
CA). For affinity purification of the anti-rAPH0859 serum, 3 ml
anti-rAPH0859 serum was incubated with 1 ml of rAPH0859-
conjugated Affi-Gel 10 (Bio-Rad). After washing with TBS
(150 mM NaCl, 50 mM Tris-HCl, pH 7.4), the antibody was
eluted using 0.1 M glycine-HCl, pH 2.5. Eluted antibody was
neutralized by addition of 0.1 volume of 1.0 M Tris-HCl, pH 8.8.
Protein identification by mass spectrometry
A. phagocytophilum–infected HL-60 cells (1.0610
8 cells) were
pelleted by centrifugation, washed twice with cold PBS buffer
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM
KH2PO4, pH 7.4), and lysed in 2.0 ml cold lysis buffer (150 mM
NaCl, 1 mM EDTA, 20 mM Tris-HCl, pH 7.5) containing 1%
(v/v) Triton X-100 and 2% (v/v) protease inhibitor cocktail set III
(EMD Chemicals, San Diego, CA). The lysate was pre-cleared
with 100 ml protein A-agarose (Santa Cruz Biotechnology, Santa
Cruz, CA), and incubated with 50 mg affinity-purified rabbit anti-
rAPH0859 antibody or rabbit pre-immune IgG for 2 h at 4uC.
The immune complex was precipitated by addition of 300 ml
protein A-agarose and incubated overnight. The protein A-
agarose was washed four times with PBS, and bound protein was
eluted by the addition of 100 ml SDS-PAGE loading buffer (4%
SDS, 135 mM Tris-HCl, pH 6.8, 10% (v/v) glycerol, and 10%
(v/v) b-mercaptoethanol) and boiled for 5 min. Proteins were
separated by SDS-PAGE and the 48-kDa band, which was
specifically immunoprecipitated by anti-rAPH0859 antibody, was
excised, digested with chymotrypsin, and subjected to protein
identification using LC-MS-MS (Mass Spectrometry & Proteomics
Facility at Ohio State University) after fixation and staining with
GelCode Blue (Pierce).
Time-course infection by A. phagocytophilum
Infection of HL-60 cells or human neutrophils with host cell-
free A. phagocytophilum was performed as described previously with
minor modifications [20]. Briefly, human neutrophils or HL-60
cells (1.5610
7 cells) were incubated with A. phagocytophilum purified
from 2610
7 infected HL-60 cells in 15 ml complete RPMI 1460
medium (approximate bacteria to host cell ratio of 100:1). After
2 h incubation at 37uC, infected cells were washed twice with PBS
to remove free bacteria, and then incubated at 37uC for the
designated time period. A. phagocytophilum-infected neutrophils or
HL-60 cells were fixed with paraformaldehyde and were subjected
to immunofluorescence labeling.
Construction of recombinant mammalian expression
plasmids for transfection
All primers used for construction of mammalian expression
plasmids are listed in Table S1. To obtain full-length ats-1, the
primers Ats-1 Forward and Ats-1 Reverse were used. Ats-1 DN17
was prepared using the primers Ats-1 delta N17 Forward and Ats-
1 Reverse. To insert the sequence encoding an HA tag within ats-
1, the DNA fragment encoding the C-terminal Ats-1 segment (HA
C1) was amplified using the primers HA Forward C1 and Ats-1
Reverse. Using the HA C1 fragment as template and the primers
HA Forward C2 and Ats-1 Reverse, HA C2 was amplified. Using
the HA C2 fragment as template and the primers HA Forward C3
and Ats-1 Reverse, HA C3 was amplified. The DNA fragment
encoding the N-terminal Ats-1 segment (HA N) was amplified
using the primers Ats-1 Forward and HA Reverse N. Finally,
based on the complimentary DNA sequence at the 39-terminus of
HA N and the 59-terminus of HA C3, the two DNA fragments
were linked by PCR, resulting the insertion of HA tag within Ats-
1. To prepare Ats-1 mutants containing substitutions at residues
46–60, the primers Ats-1 forward and AAA (or AGA) Reverse
were used to generate fragments encoding the N-terminus of Ats-
1, and the primers AAA (or AGA) Forward and Ats-1 Reverse
were used to generate fragments encoding the C-terminus of Ats-1.
Based on the complimentary DNA sequence these two DNA
fragments were linked by PCR amplification, resulting in the
amino acid substitutions in Ats-1. All of PCR products were cloned
into pEGFP-N1 vector which was pre-digested with SalI and NotI
to remove the GFP-encoding sequence (Clontech), resulting in the
following recombinant plasmids. pAts-1, encoding full-length Ats-
1; pAts-1 (30HA), encoding Ats-1 with the HA insertion between
residues 30 and 31; pAts-1 (45HA), encoding Ats-1 with the HA
insertion between residues 45 and 46; pAts-1 (60HA), encoding
Ats-1 with the HA insertion between residues 60 and 61; pAts-1
(72HA), encoding Ats-1 with the HA insertion between residues 72
and 73; pAts-1 (NGL46-48AAA), encoding Ats-1 with AAA
substitutions at residues 46–48; pAts-1 (MGK49-51AAA), encod-
ing Ats-1 with AAA substitutions at residues 49–51; pAts-1
(GKP52-54AAA), encoding Ats-1 with AAA substitutions at
residues 52–54; pAts-1 (FYH55-57AAA), encoding Ats-1 with
AAA substitutions at residues 55–57; pAts-1 (RAS58-60AGA),
encoding Ats-1 with AGA substitutions at residues 58–60; pAts-1
DN17, encoding Ats-1 with the deleted mitochondrial targeting
sequence.
Mitochondrial import and sub-mitochondrial localization
of Ats-1
Using pAts-1, pAts-1 (55–57), and pAts-1DN17 as template, and
primers (Ats-1 Free N Forward, Ats-1 Free N delta 17 Forward,
and Ats-1 Free N Reverse) listed in the Table S1, ats-1, ats-1 (55–
57) and ats-1 DN17 were cloned into the pET41(+) vector
(Novagen). In vitro transcription/translation from the T7 promoter
was performed using TnT Coupled Reticulocyte Lysate System
(Promega) in the presence of
35S-methionine/cysteine (Perkin-
Elmer) according to the manufacturer’s instruction. The final
protein products contain additional 8 histidines at the carboxy-
terminus derived from vector. Mitochondria isolation and in vitro
import were performed as described previously [51]. Import
samples were subsequently treated with 50 mg/ml of protease K,
which was inhibited by the addition of 2 mM phenylmethylsul-
phonyl fluoride (PMSF).
For trypsin-pretreatment of mitochondria, isolated mitochon-
dria were treated with 0.02 mg/ml of trypsin for 10 min on ice.
Trypsin was inhibited by the addition of 30-fold excess of soybean
trypsin inhibitor (STI). In the control (- trypsin) samples, STI was
added before the addition of trypsin. Mitochondria were
reisolated, washed once with sucrose buffer (250 mM sucrose,
10 mM Tris, pH 7.6, 1 mM EDTA, pH 8.0) with addition of
1 mg/ml STI, and used for in vitro import.
35S-labeled proteins
were detected using autoradiography and signals were quantified
using the ImageQuant program.
For swelling of mitochondria, mitochondria were incubated in
isotonic sucrose buffer, or hypotonic ET buffer (10 mM Tris,
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resuspended in 100 ml of sucrose buffer and treated with 50 mg/ml
of PK where indicated. For complete solubilization of mitochon-
dria, 1% Triton X-100 in detergent buffer (20mM Tris–HCl,
0.1 mM EDTA, 1 mM PMSF, 50 mM NaCl, 10% (v/v) glycerol,
pH 7.4) was used. Samples were then treated with 50 mg/ml of PK
and proteins were precipitated using trichloroacetic acid.
To determine the sub-mitochondrial location of Ats-1, mito-
chondria were isolated from Ats-1, or Ats-1 (55–57)-transfected
HeLa cells, and subjected to carbonate extraction with 100 mM
Na2CO3, pH 11.5. After centrifugation for 1 h at 100,0006g,
pellet and supernatant fractions were separated and, together with
total mitochondria, analyzed by SDS-PAGE and Western blot.
The membrane was probed with Ats-1, Tom40 and Hsp60
antibodies.
Immunofluorescence microscopy
For immunofluorescence labeling in HL-60 and RF/6A cells,
cells were fixed with 2% paraformaldehyde in PBS at RT for
25 min and then washed three times with PBS before labeling.
Permeabilization and blocking were performed using PGS solution
(PBS containing 0.4% BSA, 0.2% gelatin and 0.3% saponin) at
RT for 1 h. For the determination of Ats-1 translocation in A.
phagocytophilum-infected HL-60 cells, double immunofluorescence
labeling was performed using rabbit anti-Ats-1 and monoclonal
5C11 (anti-P44) antibodies [28], with Alexa Fluor 555-conjugated
goat anti-rabbit IgG and Alexa Fluor 488-conjugated goat anti-
mouse IgG (Molecular Probes) as secondary antibodies. To
investigate the targeting of translocated Ats-1 to mitochondria in
A. phagocytophilum-infected HL-60 cells or human neutrophils, triple
immunofluorescence labeling was performed using horse anti-A.
phagocytophilum serum, affinity-purified rabbit anti-Ats-1 antibody,
and mouse monoclonal anti–Mn-Sod antibody (clone MnS-1,
Alexis, San Diego, CA), with Affipure Cy3-conjugated goat anti–
horse IgG (Jackson ImmunoResearch Laboratories), Alexa Fluor
488–conjugated goat anti-rabbit IgG and Alexa Fluor 350-
conjugated goat anti-mouse IgG (Molecular Probes) as secondary
antibodies. To stain Mn-Sod, Bax, or cytochrome c in pAts-1-,
pAts-1 (55–57), or pGFP-transfected RF/6A cells, cells were
labeled with rabbit anti-Ats-1 and mouse monoclonal anti–Mn-
Sod, mouse monoclonal anti-Bax (Clone 3, BD Transduction
Laboratory), or anti-cytochrome c (clone 2G8, Santa Cruz
biotechnology), with Alexa Fluor 488-conjugated goat anti-rabbit
IgG and Alexa Fluor 555-conjugated goat anti-mouse IgG
(Molecular Probes) as secondary antibodies. To detect induction
of apoptosis in transfected RF/6A cells, nuclei of RF/6A cells were
stained with 300 nM 49,6-diamidino-2-phenylindole, dilactate
(DAPI dilactate, Molecular Probes) for 5 min and then visualized
under a fluorescence microscope. The permeabilized cells were
incubated with the indicated primary antibodies in PGS solution
for 1 h. The cells were washed with PBS three times to remove
unbound antibody; bound antibodies were detected using the
indicated dye-conjugated secondary antibodies.
For immunofluorescence labeling in S. cerevisiae, yeast cells were
fixed in 4% paraformaldehyde solution for 1 h, and digested with
lyticase (Sigma) at the final concentration of 100 U/ml for 30 min.
Yeast cells were permeabilized with 220uC methanol for 5 min,
and subjected to immunostaining with rabbit anti-Ats-1 antibody,
and Alexa Fluor 488-conjugated goat anti-rabbit IgG.
Fluorescence images were observed using a Nikon Eclipse E400
fluorescence microscope with a xenon-mercury light source (Nikon
Instruments, Melville, NY) or using an LSM 510 laser-scanning
confocal microscope (Carl Zeiss, Thornwood, NY). A 3-D model
was reconstructed with ZEN software (Zeiss) based on the Z-stack
confocal slices. The original color emitted by excited Alexa Fluor
350 (blue), and DAPI (blue) was transformed to gray pseudocolor
using Photoshop 7.0 software (Adobe, San Jose, CA).
Immunofluorescence microscopy of HeLa cells was performed
as described previously [71].
Transfection
HeLa cells were transfected with pEGFP-N1 plasmids contain-
ing Ats-1, Ats-1 (55–57), or pAts-1DN17 genes using Lipofecta-
mine 2000 (Invitrogen) according to the manufacturer’s protocol.
RF/6A endothelial cells were transfected by electroporation as
previously described [72]. Briefly, RF/6A cells were washed once
with PBS and resuspended in RPMI-1640 without serum at a final
cell density of 2610
7/ml. RF/6A cells (80 ml) were then mixed
with 5 mg recombinant plasmid in a 0.2-cm cuvette and subjected
to electroporation using the Gene Pulser Xcell System (Bio-Rad) at
100 V and 1000 mF.
Induction of apoptosis and PARP cleavage
Transfected RF/6A cells (1.6610
5) growing on glass coverslips
in 2 ml advanced MEM were treated with 100 mM etoposide
(Sigma) for 1 day after 20 h post-transfection. Cells then were fixed
with 2% paraformaldehyde for fluorescence microscopy to
visualize cell morphology, nucleus condensation and fragmenta-
tion, and release of cytochrome c into the cytosol. To investigate
the cleavage of PARP in apoptosis induction, RF/6A cells
transfected with pAts-1, pAts-1 (55–57), or pGFP, were treated
with 100 mM etoposide (Sigma) for 12 h after 20 h post-
transfection, and subjected to Western blot analysis.
Western blot analysis
For determining Ats-1, Mn-Sod, HA, actin, or Bax in A.
phagocytophilum-infected HL-60 cells (2610
6, .95% infected),
Percoll-purified A. phagocytophilum pellet, or transfected RF/6A
cells (1.6610
6), cells were dissolved in 100 ml SDS-PAGE loading
buffer, and boiled for 5 min. For detecting PARP cleavage, RF/
6A cells (1.6610
6) were lysed in 200 ml sample buffer (6 M urea,
62.5 mM Tris-HCl, 10% glycerol, 5% b-mercaptoethanol, 2%
SDS, 0.00125% bromophenol blue, pH 6.8), sonicated for 15 s,
and incubated at 65uC for 15 min. Samples were separated by
10% SDS-PAGE, and transferred to a nitrocellulose membrane
using a semi-dry blotter (WEP, Seattle, WA). The membrane was
blocked using 5% (w/v) skim milk in TBS (pH 7.5), then
incubated with rabbit anti-Ats-1 antibody (1:1,000 dilution),
mouse monoclonal anti-HA antibody (HA.11, Clone 16B12,
Covance, Emeryville, CA, 1:1,000 dilution), rabbit anti-Mn-Sod
(Stressgen, 1:2,000 dilution), rabbit anti-actin (Sigma, 1:2,000
dilution), mouse monoclonal anti-Bax (1:500), or rabbit anti-PARP
(Cell Signal Technology, Danvers, MA, 1:1,000 dilution) at 4uC
for 12 h, and subsequently with a 1:2,000 dilution of peroxidase-
conjugated goat anti-rabbit IgG or peroxidase-conjugated goat
anti-mouse IgG (KPL, Gaithersburg, MD) at RT for 3 h. Bound
antibodies were detected using chemiluminescence (Pierce Bio-
technology, Rockford, IL). For studying Ats-1 import into
mitochondria, and sub-mitochondrial localization, Western blot
analysis was performed using anti-Tim44 (BD Transduction
laboratories), - Mitofilin (Abcam), -Tom40 (Santa Cruz Biotech-
nology), or -Hsp60 (Stressgen) antibodies. For studying Ats-1
expression and Bax translocation in yeast cells, Western blot
analysis was performed using anti-Ats-1, -Bax, or - S. cerevisiae
porin (Invitrogen). The images were captured using a CCD
camera (Fuji LAS-3000 imaging system), and band density was
measured by Fujifilm MultiGauge software.
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translocation of Bax to mitochondria in Saccharomyces
cerevisiae
The DNA fragments encoding Ats-1 and Ats-1 (55–57) was
amplified using primers Ats-1Y Forward and Ats-1Y Reverse
(Table S1), and cloned into yeast constitutive expression vector
pGADT7 AD (Clontech), resulting recombinant plasmids pYAts-
1, and pYAts-1(55–57). DNA fragment encoding Bax was
generated by using human neutrophil cDNA [20] as a template,
and the primers Bax Forward and Bax Reverse (Table S1), and
cloned into an inducible vector pYES2/ NT A (Invitrogen),
resulting plasmid pBax. Three pairs of plasmids (pBax and
pGADT7 AD, pBax and pYAts-1(55–57), pBax and pYAts-1)
were co-transformed into S. cerevisiae haploid strain YPH499
(MATa ade2-101 his3-D200 leu2-D1 lys2-801 trp1-D63 ura3-52)
(ATCC) by using YEASTMAKER Yeast Transformation System
2 (Clontech). Recombinant yeast cells were cultured in synthetic
medium lacking uracil and leucine, and supplemented with 2%
dextrose (SD medium) or 2% galactose (SG medium), specified
elsewhere [73]. To determine the localization of Ats-1, and Ats-1
(55–57) in yeast cells, recombinant YPH499 cells were cultured in
SG medium to 0.5 OD (A600), followed by incubation with
800 nM MitoTracker Red CMXRos (Invitrogen) for 30 min.
Yeast cells were fixed and subjected to immunostaining with anti-
Ats-1 antibody. To test whether Ats-1 could relieve the Bax-
induced growth inhibition in yeast cells, recombinant YPH499
strains were cultured in liquid SD media overnight at 30uC,
centrifuged and washed once with SG media, followed by dilution
to 0.05 OD (A600) in SG media. Diluted recombinant YPH499
cells were cultured in SG media to induce Bax expression for five
days. The viable yeast cells were determined at day 0 and day 5 by
plate count technique.
To investigate Bax translocation to mitochondria in pBax and
pGADT7 AD-, pBax and pYAts-1(55–57)-, or pBax and pYAts-1-
co-transformed YPH499 cells, mitochondria were isolated from
recombinant yeast cells after being cultured in Bax expression-
inducing SG media for 12 h, according to described protocol [74].
Isolated mitochondria, along with yeast cell lysates, were subjected
to Western blot, using anti-Ats-1, and anti- S. cerevisiae porin.
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